Euro Results Round-Up: Galenica, Recordati And Karo Pharma
The latest Q2 and first-half financial results from European consumer health players. Featuring Switzerland's Galenica, Italy's Recordati and Sweden's Karo Pharma.
You may also be interested in...
The latest European business news: Galenica strengthens its porfolio in Switzerland with Spagyros; Sweden's Karo offloads OTCs to Evolan; and Ceres Pharma sold to French private-equity firm.
Galenica has acquired an OTC portfolio from Switzerland's Dr. Wild, led by the market leading vitamin D supplements Vitamin D3 Wild Oil and VI-DE 3, which generated sales of CHF19m in 2020.
EU Business Round-Up: ColdZyme Heading To MENA, Kerry Expands Probiotics Offering, Galenica Launches Vita-Merfen
Latest EU company news: Enymatica strikes deal to take its ColdZyme common cold product into MENA; Ireland's Kerry snaps up Canadian probiotics specialist Bio-K Plus; and Switerland's Galenica relaunches Vita-Merfen after a five-year absence.